alexa Monte S Willis | University of North Carolina at Chapel
ISSN: 2167-1095

Journal of Hypertension: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Monte S Willis

Monte S Willis Monte S Willis
Campus Health Services Laboratory
University of North Carolina at Chapel Hill USA
Read Interview session with Monte S Willis

Dr. Willis received his MD/PhD training at the University of Nebraska Medical Center (1993-2001).  He is currently a tenure track Associate Professor in the Department of Pathology & Laboratory Medicine at the University of North Carolina at Chapel Hill.  He is Laboratory Director of the UNC Campus Health Services, Assistant Director of the Clinical Chemistry Laboratory at UNC Hospitals, and a principal investigator in the McAllister Heart Institute.  He currently serves as an editorial member of 8 journals, including the American Journal of Pathology, American Journal of Cardiovascular Disease, Journal of Molecular and Cellular Cardiology, and American Journal of Physiology Heart and Circulatory Physiology.  He has authored 140 peer reviewed manuscripts and book chapters and edited 1 book.  He is a fellow of the College of American Pathologists and American Society of Clinical Pathology, and member of the American Heart Association, American Society of Investigative Pathology, and International Society for Heart Research. 

Research Interest

The focus on my laboratory is in investigating the role of the ubiquitin proteasome system in common cardiac and vascular diseases such as heart failure, ischemic heart disease and atherosclerosis.  We have discovered that specific E3 ubiquitin ligases, which tag specific proteins for degradation, interact with a host of intracellular signaling pathways that regulate cardiovascular metabolism and muscle mass in ways that are cardioprotective in disease models in vivo.  We are currently developing ways to regulate these ubiquitin ligases for therapeutic use in pre-clinical models.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version